Krystal Biotech, Inc. KRYS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $501.31M+62.4% | $496.3M+43.9% | $392.6M+5.0% | $353.83M+2.3% | $308.77M-14.0% | ||
| $322.09M+4.5% | $331.49M+31.2% | $338.47M+57.9% | $328.16M+53.5% | $308.08M+71.9% | ||
| $495.52M+21.3% | $471.76M+15.1% | $449.08M+29.3% | $416.74M+60.7% | $408.54M+162% | ||
| $151.79M+74.1% | $139.09M+104% | $125.12M+156% | $106.07M+199% | $87.21M+260% | ||
| $1.02B+33.0% | $1.02B+38.1% | $925.65M+29.8% | $841.35M+23.2% | $766.8M+27.3% | ||
| $153.58M+1.7% | $150.78M-2.8% | $148.87M-4.9% | $150.39M-5.3% | $151.07M-5.6% | ||
| $1.4B+30.0% | $1.33B+26.3% | $1.24B+26.2% | $1.14B+24.1% | $1.07B+25.9% | ||
| $4.09M+53.0% | $3.24M-35.0% | $2.1M-62.4% | $7.12M+31.3% | $2.67M-50.1% | ||
| $107.8M+35.6% | $102.94M+0.9% | $91.27M+1.9% | $86.9M+20.9% | $79.49M+67.0% | ||
| $120.24M+34.0% | $114.23M+4.4% | $102.22M+6.0% | $97.75M+24.1% | $89.74M+66.0% | ||
| 80M0.0% | 80M— | 80M0.0% | 80M0.0% | 80M0.0% | ||
| $80.1M+155% | $24.16M+113% | -$27.24M+88.0% | -$106.6M+57.9% | -$144.94M+46.1% | ||
| $1.28B+29.7% | $1.22B+28.9% | $1.14B+28.5% | $1.04B+24.1% | $984.67M+23.2% | ||
| $1.4B+30.0% | $1.33B+26.3% | $1.24B+26.2% | $1.14B+24.1% | $1.07B+25.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Krystal Biotech, Inc.'s total assets?
- Krystal Biotech, Inc. (KRYS) holds $1.4B in total assets, up 30.0% year over year.
- How much debt does Krystal Biotech, Inc. have?
- Krystal Biotech, Inc. carries $9.1M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Krystal Biotech, Inc. have?
- Krystal Biotech, Inc. holds $501.3M in cash and equivalents.
- Can Krystal Biotech, Inc. cover its short-term obligations?
- Its current ratio is 9.46 — current assets exceed current liabilities.
- Where does Krystal Biotech, Inc.'s balance sheet data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
